Difference between revisions of "Team:Lethbridge/Team"

Line 194: Line 194:
 
   </div>
 
   </div>
  
−
<div class="row">
+
<div class="row"> <!-- Team Row 1 -->
 
       <div class="col s6 m3 l2">
 
       <div class="col s6 m3 l2">
 
         <div class="card small">
 
         <div class="card small">
Line 255: Line 255:
 
   </div>
 
   </div>
 
</div>
 
</div>
 +
<div class="col s6 m3 l2">
 +
  <div class="card small">
 +
    <div class="card-image waves-effect waves-block waves-light">
 +
      <img class="activator" style="height:100%;" src="http://www.freeiconspng.com/uploads/profile-icon-9.png">
 +
    </div>
 +
    <div class="card-content">
 +
      <span class="card-title activator grey-text text-darken-4">Dr. Fink Wibbler<i class="material-icons right">more_vert</i></span>
 +
      <p><a href="#">Dr. Finkle Wibbler</a></p>
 +
    </div>
 +
    <div class="card-reveal">
 +
      <span class="card-title grey-text text-darken-4">Dr. Finkle Wibbler<i class="material-icons right">close</i></span>
 +
      <p>Here is some more information about this product that is only revealed once clicked on.</p>
 +
    </div>
 +
  </div>
 +
</div>
 +
<div class="col s6 m3 l2">
 +
  <div class="card small">
 +
    <div class="card-image waves-effect waves-block waves-light">
 +
      <img class="activator" style="height:100%;" src="http://www.freeiconspng.com/uploads/profile-icon-9.png">
 +
    </div>
 +
    <div class="card-content">
 +
      <span class="card-title activator grey-text text-darken-4">Dr. Fink Wibbler<i class="material-icons right">more_vert</i></span>
 +
      <p><a href="#">Dr. Finkle Wibbler</a></p>
 +
    </div>
 +
    <div class="card-reveal">
 +
      <span class="card-title grey-text text-darken-4">Dr. Finkle Wibbler<i class="material-icons right">close</i></span>
 +
      <p>Here is some more information about this product that is only revealed once clicked on.</p>
 +
    </div>
 +
  </div>
 
</div>
 
</div>
 +
</div> <!-- END OF ROW 1 -->
  
−
<div class="row">
+
<div class="row"> <!-- Team Row 2 -->
 
       <div class="col s6 m3 l2">
 
       <div class="col s6 m3 l2">
 
         <div class="card small">
 
         <div class="card small">
Line 318: Line 348:
 
   </div>
 
   </div>
 
</div>
 
</div>
 +
<div class="col s6 m3 l2">
 +
  <div class="card small">
 +
    <div class="card-image waves-effect waves-block waves-light">
 +
      <img class="activator" style="height:100%;" src="http://www.freeiconspng.com/uploads/profile-icon-9.png">
 +
    </div>
 +
    <div class="card-content">
 +
      <span class="card-title activator grey-text text-darken-4">Dr. Fink Wibbler<i class="material-icons right">more_vert</i></span>
 +
      <p><a href="#">Dr. Finkle Wibbler</a></p>
 +
    </div>
 +
    <div class="card-reveal">
 +
      <span class="card-title grey-text text-darken-4">Dr. Finkle Wibbler<i class="material-icons right">close</i></span>
 +
      <p>Here is some more information about this product that is only revealed once clicked on.</p>
 +
    </div>
 +
  </div>
 +
</div>
 +
<div class="col s6 m3 l2">
 +
  <div class="card small">
 +
    <div class="card-image waves-effect waves-block waves-light">
 +
      <img class="activator" style="height:100%;" src="http://www.freeiconspng.com/uploads/profile-icon-9.png">
 +
    </div>
 +
    <div class="card-content">
 +
      <span class="card-title activator grey-text text-darken-4">Dr. Fink Wibbler<i class="material-icons right">more_vert</i></span>
 +
      <p><a href="#">Dr. Finkle Wibbler</a></p>
 +
    </div>
 +
    <div class="card-reveal">
 +
      <span class="card-title grey-text text-darken-4">Dr. Finkle Wibbler<i class="material-icons right">close</i></span>
 +
      <p>Here is some more information about this product that is only revealed once clicked on.</p>
 +
    </div>
 +
  </div>
 
</div>
 
</div>
 +
</div> <!-- END OF ROW 2 -->
  
−
<div class="row">
+
<div class="row"> <!-- Team Row 3 -->
 
       <div class="col s6 m3 l2">
 
       <div class="col s6 m3 l2">
 
         <div class="card small">
 
         <div class="card small">
Line 381: Line 441:
 
   </div>
 
   </div>
 
</div>
 
</div>
 +
<div class="col s6 m3 l2">
 +
  <div class="card small">
 +
    <div class="card-image waves-effect waves-block waves-light">
 +
      <img class="activator" style="height:100%;" src="http://www.freeiconspng.com/uploads/profile-icon-9.png">
 +
    </div>
 +
    <div class="card-content">
 +
      <span class="card-title activator grey-text text-darken-4">Dr. Fink Wibbler<i class="material-icons right">more_vert</i></span>
 +
      <p><a href="#">Dr. Finkle Wibbler</a></p>
 +
    </div>
 +
    <div class="card-reveal">
 +
      <span class="card-title grey-text text-darken-4">Dr. Finkle Wibbler<i class="material-icons right">close</i></span>
 +
      <p>Here is some more information about this product that is only revealed once clicked on.</p>
 +
    </div>
 +
  </div>
 +
</div>
 +
<div class="col s6 m3 l2">
 +
  <div class="card small">
 +
    <div class="card-image waves-effect waves-block waves-light">
 +
      <img class="activator" style="height:100%;" src="http://www.freeiconspng.com/uploads/profile-icon-9.png">
 +
    </div>
 +
    <div class="card-content">
 +
      <span class="card-title activator grey-text text-darken-4">Dr. Fink Wibbler<i class="material-icons right">more_vert</i></span>
 +
      <p><a href="#">Dr. Finkle Wibbler</a></p>
 +
    </div>
 +
    <div class="card-reveal">
 +
      <span class="card-title grey-text text-darken-4">Dr. Finkle Wibbler<i class="material-icons right">close</i></span>
 +
      <p>Here is some more information about this product that is only revealed once clicked on.</p>
 +
    </div>
 +
  </div>
 
</div>
 
</div>
 +
</div> <!-- END OF ROW 3 -->
  
  

Revision as of 20:21, 15 October 2016

Lethbridge iGEM 2016



Nanoresponder

Single-domain antibody production.
Explore


Introduction

The prevalence of virulent and multiple antibiotic resistant pathogens in healthcare facilities has resulted in ongoing reassessment of best practices to prevent their transmission. However, whether pathogen reservoirs exist in emergency medical services (EMS) vehicles, remains largely unknown. Our iGEM team developed a custom bacterial two hybrid system to select single-domain antibodies (nanobodies) that recognize human pathogens. Informed by our Nanopore next generation sequencing of DNA samples from ambulance vehicles, antibodies targeting important pathogens were then used to develop a rapid and low cost ELISA-based testing kit that may be employed on-site by EMS workers. Our project provides a framework for rapid detection of emergent pathogens and a practical and rapid solution for monitoring their presence in and outside of the healthcare system.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

Dr. Fink Wibblermore_vert

Dr. Finkle Wibbler

Dr. Finkle Wibblerclose

Here is some more information about this product that is only revealed once clicked on.

I am a very simple card. I am good at containing small bits of information. I am convenient because I require little markup to use effectively. I am similar to what is called a panel in other frameworks.
Overview

The prevalence of virulent and multiple antibiotic resistant pathogens in healthcare facilities has resulted in ongoing reassessment of best practices to prevent their transmission. However, whether pathogen reservoirs exist in emergency medical services (EMS) vehicles, remains largely unknown. Our iGEM team developed a custom bacterial two hybrid system to select single-domain antibodies (nanobodies) that recognize human pathogens. Informed by our Nanopore next generation sequencing of DNA samples from ambulance vehicles, antibodies targeting important pathogens were then used to develop a rapid and low cost ELISA-based testing kit that may be employed on-site by EMS workers. Our project provides a framework for rapid detection of emergent pathogens and a practical and rapid solution for monitoring their presence in and outside of the healthcare system.

Our Project
Human Practices